Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 1

A First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of HMB-003 in Healthy Volunteers

Hemab ApS · NCT07798505

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–50 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Phase 1
Target enrollment
40
US sites recruiting
1
Study start
August 17, 2026
Record last updated
September 10, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The purposes of this clinical study are

  • To see how the new drug (HMB-003) under study is tolerated in healthy volunteers, and if there are any important side effects.
  • To measure the amount of HMB-003 in the body after injection.

Being studied: HMB-003; Placebo

Conditions: Healthy Adult Participants

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Participant is aged 18 to 50 years, inclusive, at the time of signing informed consent.
  • Overall healthy as determined by medical evaluation including physical examination, vital signs, laboratory tests, and ECG.

Exclusion Criteria

  • Participant has a history of clinically significant hypersensitivity to any excipients of the study drug
  • Participant is pregnant, breastfeeding, or \<6 weeks postpartum.
  • Participant has received investigational drug or device in another clinical study within 30 days or 5 half-lives, whichever is longer, before dosing.

Recruiting US locations

  • Worldwide Clinical Trials

    San Antonio, TX 78217

    Site contact: Worldwide Clinical Trials · 210-635-1515 · participate@worldwide.com

Study contacts (from the official record)

  • Clinical Trials · 001 888 493 8148 · clinicaltrials@hemab.com
All healthy volunteers studies in Texas →
A First-in-Human Study to Assess the Safety, Pharmacokinetics, and… (NCT07798505) | Bored Studies